sarecycline 150 MG Oral Tablet [Seysara]

RxCUI: 2059033
RxNorm name: sarecycline 150 MG Oral Tablet [Seysara]
Display name: sarecycline 150 MG Oral Tablet [Seysara]
Full name: sarecycline 150 MG Oral Tablet [Seysara]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:16

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Seysara	SARECYCLINE HYDROCHLORIDE	Almirall, LLC	b200957c-3004-4988-be97-9fd619a83649	2024-06-05	Warnings, Adverse reactions	Exact identifier rxcui: 2059033

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
b200957c-3004-4988-be97-9fd619a83649	Seysara 150 MG Oral Tablet [PSN] · sarecycline 150 MG Oral Tablet [Seysara] [SBD] · Seysara 150 MG (as sarecycline HCl 161.2 MG) Oral Tablet [SY]	3	12	These highlights do not include all the information needed to use SEYSARA ® safely and effectively. See full prescribing information for SEYSARA ® . SEYSARA ® (sarecycline) tablets for oral use. Initial U.S. Approval: 2018	20240605